MSH|^~\&|||||20190714082215-0400||VXU^V04^VXU_V04|kH-A.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S13W75535^^^MAA^MR||Tillman^Valerie^Ramla^^^^L|Hore^Sashi^^^^^M|20170723|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|9 Magri St^^Paw Paw^MI^49079^USA^L||^PRN^PH^^^269^9114048|||||||||2186-5^non Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20190529|20190529NK1|1|Tillman^Hore^^^^^L|MTH^Mother^HL70063|9 Magri St^^Paw Paw^MI^49079^USA^L|^PRN^PH^^^269^9114048ORC|RE||BS13W75535.1^NDA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190714||140^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001|7832-1^Lemon^Mike^A^^^^^NIST-AA-1|^^^B31||||J6702KP|20191113|PMC^sanofi pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20190712|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190714||||||FMSH|^~\&|||||20190714082215-0500||VXU^V04^VXU_V04|kH-A.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I68H75540^^^MAA^MR~184-25-4562^^^MAA^SS||Berntsen^Angwyn^^^^^L||19480610|M|||||^~^NET^^Eisig@hotmail.comORC|RE||BI68H75540.1^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20190714||115^Tdap^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^0||||Z79YG|20191113|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20190712|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|139^Td(adult) unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20130509||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190714||||||FMSH|^~\&|||||20190714082215-0500||VXU^V04^VXU_V04|kH-A.01.03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C18S75551^^^MAA^MR||Lapeer^Tigerlily^^^^^L||20080912|FORC|RE||BC18S75551.1^NDARXA|0|1|20180227||83^Hep A^CVX|999|||01^Historical information - source unspecified^NIP001MSH|^~\&|||||20190714082215-0500||VXU^V04^VXU_V04|kH-A.01.04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z93I75562^^^MAA^MR||Stark^Kylie^^^^^L||20080825|FPD1||||||||||||N|20190714ORC|RE||BZ93I75562.1^NDARXA|0|1|20180226||118^HPV^CVX|999|||01^Historical information - source unspecified^NIP001MSH|^~\&|||||20190714082215-0500||VXU^V04^VXU_V04|kH-A.01.05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P26M75567^^^MAA^MR||Morris^Krunal^^^^^L||20170805|MORC|RE||BP26M75567.1^CDCRXA|0|1|20190714||03^MMR^CVX|999||||||||||||00^Parental Refusal^NIP002||REMSH|^~\&|||||20190714082215-0500||VXU^V04^VXU_V04|kH-A.01.06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L87P75572^^^NIST MPI^MR||Minidoka^Galatea^^^^^L||20080910|FORC|RE||BL87P75572.1^CDCRXA|0|1|20180227||998^No vaccine administered^CVX|999||||||||||||||NAOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||FMSH|^~\&|||||20190714082215-0500||VXU^V04^VXU_V04|kH-A.01.07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R39W75580^^^MAA^MR||Estill^Giovanny^Blake^^^^L||20160718|MORC|RE||BR39W75580.1^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20190714||140^Influenza^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||W1356FE|20191113|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20190531|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190714||||||FORC|RE||BR39W75580.2^NDARXA|0|1|20180113||133^PCV 13^CVX|999|||01^Historical information - source unspecified^NIP001ORC|RE||BR39W75580.3^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20190714||110^DTaP-Hep B-IPV^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||78HH34I|20191113|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20190531|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|107^DTaP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20070517||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190714||||||FOBX|5|CE|30956-7^vaccine type^LN|3|89^Polio^CVX||||||FOBX|6|TS|29768-9^Date vaccine information statement published^LN|3|20111108||||||FOBX|7|TS|29769-7^Date vaccine information statement presented^LN|3|20190714||||||FOBX|8|CE|30956-7^vaccine type^LN|4|45^Hep B, unspecified formulation^CVX||||||FOBX|9|TS|29768-9^Date vaccine information statement published^LN|4|20120202||||||FOBX|10|TS|29769-7^Date vaccine information statement presented^LN|4|20190714||||||FMSH|^~\&|||||20190714140619-0400||VXU^V04^VXU_V04|kH-A0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z36P75583^^^AIRA-TEST^MR||Lee^Tainn^Palomi^^^^L|Pittsburg^Volumnia^^^^^M|20150514|F||2106-3^White^CDCREC|155 Manistee Cir^^Kenockee^MI^48006^USA^P||^PRN^PH^^^810^9006660|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20190714|20190714NK1|1|Lee^Pittsburg^^^^^L|MTH^Mother^HL70063|155 Manistee Cir^^Kenockee^MI^48006^USA^P|^PRN^PH^^^810^9006660ORC|RE||BZ36P75583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190514||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ36P75583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190714||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20190714|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190714||||||F